Partner Content Partner Content Official Invitation from Chair of RNA Therapeutics 2019 Conf... Invitation from Chair of RNA Therapeutics 2019
Partner Content Partner Content Updates on Delivery Mechanisms of RNA-Based Drugs at RNA The... Updates on Delivery Mechanisms of RNA-Based Drugs
News GSK pursues $10.6bn takeover of cancer biotech Nuvalent GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
